Lataa...
Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus
No commercial vaccine is yet available against Group A Streptococcus (GAS), major cause of pharyngitis and impetigo, with a high frequency of serious sequelae in low- and middle-income countries. Group A Carbohydrate (GAC), conjugated to an appropriate carrier protein, has been proposed as an attrac...
Tallennettuna:
| Julkaisussa: | Int J Mol Sci |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7696035/ https://ncbi.nlm.nih.gov/pubmed/33202815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21228558 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|